
53.83 Delayed Data As of Feb 02 | ![]() Today’s Change | 47.88 Today|||52-Week Range 58.98 | +4.02% Year-to-Date |
Dr. Reddy's (RDY) Q3 Earnings & Revenues Beat Estimates Jan 27 / Zacks.com - Paid Partner Content |
Previous close | 53.88 |
Today’s open | 53.92 |
Day’s range | 53.36 - 53.92 |
Volume | 235,183 |
Average volume (3 months) | 213,750 |
Market cap | $8.9B |
Earnings growth (last year) | +36.18% |
Earnings growth (this year) | +55.53% |
Earnings growth (next 5 years) | +21.15% |
Revenue growth (last year) | +12.59% |
P/E ratio | 20.2 |
Price/Sales | 3.22 |
Price/Book | 3.52 |
Today’s change | Today’s % change | |
---|---|---|
JAZZJazz Pharmaceuticals... | -1.37 | -0.87% |
CTLTCatalent Inc | +0.01 | +0.02% |
SRPTSarepta Therapeutics... | -2.11 | -1.72% |
RGENRepligen Corp | +4.39 | +2.30% |
Next reporting date | May 12, 2023 |
EPS forecast (this quarter) | $0.68 |
Annual revenue (last year) | $2.9B |
Annual profit (last year) | $316.3M |
Net profit margin | 10.99% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Hyderabad, Telangana |